<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37841213</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2040-6223</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Therapeutic advances in chronic disease</Title><ISOAbbreviation>Ther Adv Chronic Dis</ISOAbbreviation></Journal><ArticleTitle>Complementary and alternative medicine for long COVID: a systematic review of randomized controlled trials.</ArticleTitle><Pagination><StartPage>20406223231204727</StartPage><MedlinePgn>20406223231204727</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20406223231204727</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/20406223231204727</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Complementary and alternative medicine (CAM) interventions are growing in popularity as possible treatments for long COVID symptoms. However, comprehensive analysis of current evidence in this setting is still lacking.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aims to review existing published studies on the use of CAM interventions for patients experiencing long COVID through a systematic review.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Systematic review of randomized controlled trials (RCTs).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A comprehensive electronic literature search was performed in multiple databases and clinical trial registries from September 2019 to January 2023. RCTs evaluating efficacy and safety of CAM for long COVID were included. Methodological quality of each included trial was appraised with the Cochrane 'risk of bias' tool. A qualitative analysis was conducted due to heterogeneity of included studies.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 14 RCTs with 1195 participants were included in this review. Study findings demonstrated that CAM interventions could benefit patients with long COVID, especially those suffering from neuropsychiatric disorders, olfactory dysfunction, cognitive impairment, fatigue, breathlessness, and mild-to-moderate lung fibrosis. The main interventions reported were self-administered transcutaneous auricular vagus nerve stimulation, neuro-meditation, dietary supplements, olfactory training, aromatherapy, inspiratory muscle training, concurrent training, and an online breathing and well-being program.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">CAM interventions may be effective, safe, and acceptable to patients with symptoms of long COVID. However, the findings from this systematic review should be interpreted with caution due to various methodological limitations. More rigorous trials focused on CAM for long COVID are warranted in the future.</AbstractText><CopyrightInformation>&#xa9; The Author(s), 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0850-679X</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Kia Hui</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Kia Teng</ForeName><Initials>KT</Initials><AffiliationInfo><Affiliation>Yong Loo Lin School of Medicine, National University of Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woods</LastName><ForeName>Jeffrey T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohabbat</LastName><ForeName>Arya B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahner-Roedler</LastName><ForeName>Dietlind L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesh</LastName><ForeName>Ravindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Brent A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AT001218</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ther Adv Chronic Dis</MedlineTA><NlmUniqueID>101532140</NlmUniqueID><ISSNLinking>2040-6223</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complementary and alternative medicine</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>16</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37841213</ArticleId><ArticleId IdType="pmc">PMC10571674</ArticleId><ArticleId IdType="doi">10.1177/20406223231204727</ArticleId><ArticleId IdType="pii">10.1177_20406223231204727</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
WHO. WHO coronavirus (COVID-19) dashboard, https://covid19.who.int/ (2022, accessed 29 December 2022).</Citation></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al.. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022; 226: 1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC. Long COVID or post-COVID conditions, https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html (2022, accessed 8 March 2023; ).</Citation></Reference><Reference><Citation>Mantovani A, Morrone MC, Patrono C, et al.. Long COVID: where we stand and challenges ahead. Cell Death Differ 2022; 29: 1891&#x2013;1900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9449925</ArticleId><ArticleId IdType="pubmed">36071155</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, et al.. Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health 2022; 12: 05014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Br&#xfc;ssow H, Timmis K. COVID-19: long COVID and its societal consequences. Environ Microbiol 2021; 23: 4077&#x2013;4091.</Citation><ArticleIdList><ArticleId IdType="pubmed">34110078</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirin AA. A preliminary estimate of the economic impact of long COVID in the United States. Fatigue 2022; 10: 190&#x2013;199.</Citation></Reference><Reference><Citation>Brennan A, Broughan JM, McCombe G, et al.. Enhancing the management of long COVID in general practice: a scoping review. BJGP Open 2022; 6: bjgpo.2021.0178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9680752</ArticleId><ArticleId IdType="pubmed">35256357</ArticleId></ArticleIdList></Reference><Reference><Citation>Funke-Chambour M, Bridevaux P-O, Clarenbach CF, et al.. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration 2021; 100: 826&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339046</ArticleId><ArticleId IdType="pubmed">34091456</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilek A, Ozaras R, Ozkaya S, et al.. COVID-19-associated mucormycosis: case report and systematic review. Travel Med Infect Dis 2021; 44: 102148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387131</ArticleId><ArticleId IdType="pubmed">34454090</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigham E, O&#x2019;Toole J, Kim SY, et al.. The Johns Hopkins Post-Acute COVID-19 Team (PACT): a multidisciplinary, collaborative, ambulatory framework supporting COVID-19 survivors. Am J Med 2021; 134: 462&#x2013;467.e461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801819</ArticleId><ArticleId IdType="pubmed">33444589</ArticleId></ArticleIdList></Reference><Reference><Citation>Paudyal V, Sun S, Hussain R, et al.. Complementary and alternative medicines use in COVID-19: a global perspective on practice, policy and research. Res Social and Adm Pharm 2022; 18: 2524&#x2013;2528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116135</ArticleId><ArticleId IdType="pubmed">33992585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TH, Jeon SR, Kang JW, et al.. Complementary and alternative medicine for long COVID: scoping review and bibliometric analysis. Evid Based Complement Alternat Med 2022; 2022: 7303393.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9371860</ArticleId><ArticleId IdType="pubmed">35966751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon SR, Kang JW, Ang L, et al.. Complementary and alternative medicine (CAM) interventions for COVID-19: an overview of systematic reviews. Integr Med Res 2022; 11: 100842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8918082</ArticleId><ArticleId IdType="pubmed">35308033</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cochrane. RoB 2: a revised Cochrane risk-of-bias tool for randomized trials, https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials. (2022, accessed 29 December 2022).</Citation></Reference><Reference><Citation>Hong QN, F&#xe0;bregues S, Bartlett G, et al.. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Educ Inf 2018; 34: 285&#x2013;291.</Citation></Reference><Reference><Citation>Pires &#xcd;dA, Steffens ST, Mocelin AG, et al.. Intensive olfactory training in post-COVID-19 patients: a multicenter randomized clinical trial. Am J Rhinol Allergy 2022; 36: 780&#x2013;787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9309586</ArticleId><ArticleId IdType="pubmed">35866202</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, D&#x2019;Ascanio L, Vaira LA, et al.. Ultramicronized palmitoylethanolamide and luteolin supplement combined with olfactory training to treat post-COVID-19 olfactory impairment: a multi-center double-blinded randomized placebo-controlled clinical trial. Curr Neuropharmacol 2022; 20: 2001&#x2013;2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9886808</ArticleId><ArticleId IdType="pubmed">35450527</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almazan A, Buendia-Romero A, Martinez-Cava A, et al.. Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations on recovery from post-COVID-19 conditions: the RECOVE trial. J Appl Physiol 2023; 134: 95&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9829459</ArticleId><ArticleId IdType="pubmed">36476156</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Picca A, et al.. Effects of l-arginine plus vitamin C supplementation on physical performance, endothelial function, and persistent fatigue in adults with long COVID: a single-blind randomized controlled trial. Nutrients 2022; 14: 4984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, Owles H, McVey S, et al.. An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trial. Lancet Respir Med 2022; 10: 851&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9045747</ArticleId><ArticleId IdType="pubmed">35489367</ArticleId></ArticleIdList></Reference><Reference><Citation>Palau P, Dominguez E, Gonzalez C, et al.. Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarged patients with long COVID: the InsCOVID trial. BMJ Open Respir Res 2022; 9: 12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9791108</ArticleId><ArticleId IdType="pubmed">36549786</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy EN, Elimy DA, Ali AY, et al.. Influence of manual diaphragm release technique combined with inspiratory muscle training on selected persistent symptoms in men with post-COVID-19 syndrome: a randomized controlled trial. J Rehabil Med 2022; 54: jrm00330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9608026</ArticleId><ArticleId IdType="pubmed">36121338</ArticleId></ArticleIdList></Reference><Reference><Citation>McNarry MA, Berg RMG, Shelley J, et al.. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J 2022; 60: 2103101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins J, Hires C, Keenan L, et al.. Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: a randomized, double-blinded, placebo controlled clinical trial. Complement Ther Med 2022; 67: 102823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949693</ArticleId><ArticleId IdType="pubmed">35341944</ArticleId></ArticleIdList></Reference><Reference><Citation>Berube S, Demers C, Bussiere N, et al.. Olfactory training impacts olfactory dysfunction induced by COVID-19: a pilot study. ORL J Otorhinolaryngol Relat Spec 2023; 85: 57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843729</ArticleId><ArticleId IdType="pubmed">36529118</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Ascanio L, Vitelli F, Cingolani C, et al.. Randomized clinical trial &#x201c;olfactory dysfunction after COVID-19: olfactory rehabilitation therapy vs. intervention treatment with Palmitoylethanolamide and Luteolin&#x201d;: preliminary results. Eur Rev Med Pharmacol Sci 2021; 25: 4156&#x2013;4162.</Citation><ArticleIdList><ArticleId IdType="pubmed">34156697</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausswirth C, Schmit C, Rougier Y, et al.. Positive impacts of a four-week neuro-meditation program on cognitive function in post-acute sequelae of COVID-19 patients: a randomized controlled trial. Int J Environ Res Public Health 2023; 20: 1361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9858974</ArticleId><ArticleId IdType="pubmed">36674117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen KS, Mogensen TH, Agergaard J, et al.. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur 2023; 24: 100539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Badran BW, Huffman SM, Dancy M, et al.. A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms. Bioelectron Med 2022; 8: 13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9402278</ArticleId><ArticleId IdType="pubmed">36002874</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO. Coronavirus disease (COVID-19): post COVID-19 condition, https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition?gclid=Cj0KCQiAgaGgBhC8ARIsAAAyLfEEMYc44dOuX8CuuxLapu4dPWKXLZMtZo93OqsjV45L2eGyJII1HMEaAvRgEALw_wcB (2021, accessed 8 March 2023).</Citation></Reference><Reference><Citation>
NIH. Long COVID, https://www.nhlbi.nih.gov/covid/long-covid (2022, accessed 8 March 2023).</Citation></Reference><Reference><Citation>
NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19, https://www.nice.org.uk/guidance/ng188 (2021, accessed 8 March 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>